OTC EpiPen? US FDA Open To Switching Epinephrine For Anaphylaxis

 
• By Michael McCaughan
  
FDA outlined the ‘challenges’ facing any potential switch but emphasized ‘we are very willing to work with interested sponsors.’
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from Rx-to-OTC Switch

More from Health